Drug Type Monoclonal antibody |
Synonyms ADNC, Anti-D monoclonal antibody, Anti-RhD-antibody + [6] |
Target |
Action inhibitors |
Mechanism Rh factor inhibitors(Blood group Rh(D) polypeptide inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |


| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Erythroblastosis, Fetal | Phase 3 | France | 12 Mar 2014 | |
| Anemia, Hemolytic | Phase 2 | France | 01 Apr 2014 | |
| Rh-Null, Regulator Type | Phase 2 | France | 01 Apr 2014 | |
| Rheumatic Heart Disease | Phase 2 | France | 01 Apr 2014 |
Phase 2 | 62 | (Population PK (PKS1)) | rqxebdgkma(ejqpunufbf) = qqnabxnznk lgovlhshug (drlnbkqirp, 5.91) View more | - | 16 Aug 2019 | ||
(IM Arm Roledumab) | cncmesvnes(oudsrqycqk) = hedqpfziqc rggnkqmcan (qiqzythysk, kcwpdvpgmj - qiioqflhfa) View more |






